Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9594 posts found.

Cardiff Oncology doses first patient in colorectal cancer trial

March 1, 2024 Research and Development Cardiff Oncology, Oncology, clinical trial, colorectal cancer

Cardiff Oncology has announced that it has dosed the first patient in its randomised first-line phase 2 trial, CRDF-004, for …
News

Viatris and Idorsia enter research and development collaboration

February 28, 2024 Research and Development Idorsia, Pharmacy, Viatris, acute myocardial infarction, systemic lupus erythematosus

Viatris and Idorsia have announced that they have entered into agreements for a significant global research and development collaboration. Under …
News

Amneal and Zambon Biotech enter agreement for Parkinson’s treatment

February 28, 2024 Research and Development Amneal pharmaceuticals, Neurology, Parkinson's disease, Zambon Biotech, licensing agreement

Amneal Pharmaceuticals has announced that it has entered into an exclusive licensing agreement with Zambon Biotech for IPX204 in the …
News

GSK shares positive results from phase 3 trial for gonorrhoea treatment

February 27, 2024 Research and Development GSK, Infections and infestations, antibiotic, clinical trial, gonorrhoea

GSK has announced positive headline results from its phase 3 EAGLE-1 trial for gepotidacin, its potential first-in-class oral antibiotic with …
News

Roche shares data from phase 3 trial of Xolair as allergy treatment

February 26, 2024 Research and Development Allergic Disorders, Roche, Xolair, allergy, clinical trial, food allergy

Roche has announced data from stage 1 of the National Institutes of Health (NIH)-sponsored phase 3 OUtMATCH trial, which assessed …
News

Boehringer Ingelheim announces results from phase 2 trial for liver disease treatment

February 26, 2024 Research and Development Boehringer Ingelheim, Hepatology, clinical trial, liver disease, survodutide

Boehringer Ingelheim has announced results from the phase 2 trial of survodutide for the treatment of liver disease due to …
News

AbbVie and Tentarix collaborate on oncology and immunology treatments

February 23, 2024 Research and Development AbbVie, Oncology, collaboration, immunology

AbbVie and Tentarix Biotherapeutics have announced that they have entered a multi-year collaboration focused on the discovery and development of …
News

Almirall licenses Novo Nordisk’s anti-IL-21 monoclonal antibody for dermatology treatment

February 23, 2024 Research and Development Almirall, Dermatology, Novo Nordisk, dermatology, monoclonal antibody

Almirall has announced that it has entered into an exclusive license agreement with Novo Nordisk for the rights to its …
News

ViiV Healthcare shares interim data from phase 3 trial for injectable HIV treatment

February 21, 2024 Research and Development Cabenuva, HIV, HIV/AIDS, ViiV Healthcare, clinical trial, injectables

ViiV Healthcare has announced results from an interim analysis of the phase 3 LATITUDE trial, which assessed Cabenuva (cabotegravir and …
News

Voyager Therapeutics shares data from preclinical programmes for Alzheimer’s treatment

February 21, 2024 Research and Development Alzheimer's, Neurology, Voyager Therapeutics, preclinical

Voyager Therapeutics has announced new data from is two preclinical programmes targeting pathological tau for the treatment of Alzheimer’s disease …
News

Astellas and Kelonia Therapeutics enter agreement for development of immuno-oncology therapeutics

February 16, 2024 Research and Development Astellas Pharma, Kelonia Therapeutics, Oncology, collaboration, immuno-oncology

Astellas Pharma and Kelonia Therapeutics have announced that Xyphos Biosciences (a wholly owned subsidiary of Astellas) and Kelonia have entered …
News

Freenome raises $254m funding for early cancer detection platform

February 16, 2024 Research and Development Diagnostics, Freenome, Oncology, cancer detection, funding

Freenome has announced that it has raised $254m from new and existing investors, intended to be used for the advancement …
News

BioNTech and Autolus announce CAR T-cell therapy collaboration

February 9, 2024 Research and Development Autolus, BioNTech, CAR T-cell, Oncology, collaboration

BioNTech and Autolus Therapeutics have announced that they have entered a strategic collaboration intended to further both companies’ autologous CAR …
News

Regenxbio announces positive data from trial for MPS II treatment

February 8, 2024 Research and Development Hunter syndrome, MPS II, Neurology, Regenxbio, clinical trial

Regenxbio has announced topline results from the phase 1/2/3 CAMPSIITE trial of RGX-121 for the treatment of patients up to …
News

Tenax Therapeutics enrolls first patient in phase 3 trial for pulmonary hypertension treatment

February 8, 2024 Research and Development Cardiology, Tenax Therapeutics, clinical trial, pulmonary hypertension

Tenax Therapeutics has announced that it has enrolled the first patient in its phase 3 LEVEL study, which aims to …
News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026